WHO’s pandemic declaration forced five European69 and several African countries70 to purchase millions of doses of Glaxo’s dangerous pandemic vaccine, earning Glaxo a cool and fast $13 billion. Sanofi reported €1.95 billion profit on its swine flu vaccine revenue.
